Piper Jaffray reiterated a Neutral rating on XOMA, Ltd. (NASDAQ: XOMA), and raised the price target to $1.80 (from $1.50) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Agenus (AGEN) to Acquire XOMA's (XOMA) Biologics Manufacturing FacilitiesNovember 5, 2015 4:11 PM XOMA Announces the Sale of Its Manufacturing Facilities to AgenusNovember 5, 2015 4:10 PM XOMA (XOMA) Tops Q3 EPS by 16cNovember 5, 2015 4:02 PM XOMA Provides Corporate Update and Reports Financial Results for Third Quarter 2015November 5, 2015 4:01 PM Agenus to Acquire Antibody Manufacturing Capability, Expands Antibody Discovery and adds Cell Line Development Capabilities with Three Separate TransactionsNovember 5, 2015 4:00 PM Trading Radar for 11/5: Disney (DIS), Celgene (CELG), SeaWorld (SEAS), Sprouts (SFM), CyberArk (CYBR) ReportNovember 4, 2015 3:11 PM